Fighting for your right to try psychedelic therapy.

We conduct the research, train the clinicians, take the government to court, and stand with the patients who need this care most.

Our mission

TheraPsil is a Canadian nonprofit making psychedelic therapy accessible worldwide.

As seen in
Forbes Bloomberg CBC Maclean's The Globe and Mail Rolling Stone
The record

Small nonprofit. Outsized impact.

A core team of four, working with volunteers, committees, trainers and supporters around the world.

0+
Clinicians trained
0s
Patients supported and treated
0
Countries with trained practitioners
0/5
Average training rating
Why we do this

Approved for MAiD. Denied psilocybin therapy.

Canadians at the end of life can be approved for medical assistance in dying while being refused a non-lethal therapy their own physician recommended. That is the gap we exist to close.

We take those refusals to court, and we win. Enforcing those rulings, patient by patient, is the most urgent work we do.

As a terminal patient, I feel like my government would sooner exercise my right to medical assistance in dying than what I consider to be medical assistance in living.
Janis Hughes
Patient advocate & Stage IV cancer "thriver"
Thomas Hartle, the first Canadian to legally receive psilocybin therapy.
Our story

The right to try.

TheraPsil was founded in Victoria, British Columbia in 2019 to win Canadians access to psychedelic therapy: legally, safely, and with a doctor's guidance.

It began with Thomas Hartle, a father of two facing terminal cancer who fought for the right to try. What started as his fight has become an international effort spanning legal, clinical, and political change to make this care something anyone can reach.

Read our story
Clinical training

See what it's like to train with us.

Physicians, nurses, psychologists, counsellors, social workers, paramedics and more train with us across psilocybin and MDMA-assisted psychotherapy, in small cohorts led by practising clinicians who have done this work.

See all programs
Canadian Psychological Association Canadian Counselling and Psychotherapy Association Ordre des psychologues du Québec
Upcoming cohorts
Dave Phillips

Vancouver

with Dave Phillips

Psilocybin • Five days

October 5-9, 2026

Angela Cara

Victoria

with Angela Cara

Psilocybin • Five days

October 26–30, 2026

Dr. Ingrid Pacey

Vancouver

with Dr. Ingrid Pacey

MDMA • Six days

Nov 30-Dec 5, 2026

In their words
"Working alongside them allowed me to experience firsthand the feasibility of this kind of treatment. I also gained confidence in the surprisingly positive impact that these substances can have on individuals facing end-of-life distress."
Mathieu Leblanc
Sherbrooke, QC
"The TheraPsil psilocybin-assisted psychotherapy training was far more than just a training; it was a life altering experience. The training has influenced my practice by reinforcing the fundamental importance of presence and attunement in my work with clients."
Cheyenne Ling
Vancouver, BC
"This training has influenced me less through specific techniques and more through a fundamental shift in how I sit with others. My background in palliative care has given me extensive experience supporting people through existential distress, and this program deepened my capacity to do so with greater ease, presence, and compassion."
Tina Geis
Chilliwack, BC
"TheraPsil has given me more than I thought possible. I cannot stress enough that one will complete this program feeling confident and competent, with the type of support we all desire from our predecessors in this field."
Deborah Johansson
Edmonton, AB
"TheraPsil's training provided a structured and ethically grounded framework that complements my 20+ years of clinical and psychedelic-assisted therapeutic practice. The integration of regulatory standards with compassionate care is essential for the future of psychedelic medicine."
Nikolas Fragkias
Athens, Greece & Portugal
"My experience training with TheraPsil was profound. Their dedication to the field, love for the work, and authenticity shine through every facet of this program."
Matilda Wilson
Toronto/Orillia, ON
"My training with TheraPsil was thoughtfully structured and deeply enriching on both a personal and professional level. The trainers led with clinical integrity, as well as a genuine authenticity and humanness that fostered a learning environment that felt grounded, supportive, and expansive."
Maïa Mercure
Vancouver Island, BC
Clinical research

Psychedelics and wellness.

PsilWell is Canada's first wellness-focused psychedelic trial, run in partnership with Hippo Science, studying whether therapist-guided psilocybin can improve everyday wellbeing. It's funded by the community it serves.

About PsilWell
Common questions

Questions, answered.

Visit the full FAQ
Who can train with TheraPsil?

Physicians, nurses and nurse practitioners, psychologists, counsellors and psychotherapists, social workers, psychiatric nurses, naturopathic doctors, osteopaths and chiropractors, paramedics, death doulas, and recognised pastoral or spiritual counsellors.

Every application is reviewed individually for professional grounding and alignment with our standards of care.

Is psychedelic therapy legal in Canada?

Not generally. Patients currently access psilocybin through Health Canada's Special Access Program or individual Section 56 exemptions, both granted case by case. It is slow, expensive and inconsistent.

We are pursuing a regulated medical framework so that access works like any other prescription, decided between a patient and their physician.

I'm a patient. Where do I start?

Book a free support call with our team. We will talk through your situation, explain which pathways may be open to you, and help you find a trained practitioner from our directory.

There is no obligation and no cost for that first conversation.

What does treatment cost?

Psychedelic-assisted therapy is not yet covered by public healthcare in Canada. Full cost of care, including intake, prescriber oversight, preparation, the medicine session and integration, generally runs between $2,500 and $6,500 depending on your care team and treatment plan.

Your providers discuss specific fees with you directly, including whether sliding-scale rates apply.

Do you train clinicians outside Canada?

Yes. Alongside our Canadian cohorts we run international programs, and our clinicians now practise across 14 countries.

How is TheraPsil funded?

Training tuition and donations. We receive no government operating funding. Court applications, patient case management and our clinical trial all run on what supporters give, which is why monthly giving matters so much to us.

Every case we win is paid for by someone who cared.

Court applications, patient case management and the clinical trial all run on donations. Monthly giving is what lets us commit to a case before we know how long it will take.

Subscribe to our newsletter!

Be the first to hear about new trainings, legal updates, and community events. Join TheraPsil’s newsletter and stay connected to Canada’s psychedelic advocacy and training community.

Help expand compassionate access

Support TheraPsil’s work to improve access to psychedelic therapy for patients in Canada.

Support the campaign